BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 8035377)

  • 1. Expression of the p53 gene in trophoblastic cells in hydatidiform moles and normal human placentas.
    Cheung AN; Srivastava G; Chung LP; Ngan HY; Man TK; Liu YT; Chen WZ; Collins RJ; Wong LC; Ma HK
    J Reprod Med; 1994 Mar; 39(3):223-7. PubMed ID: 8035377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 expression in placentas with hydropic change and hydatidiform moles.
    Cheville JC; Robinson RA; Benda JA
    Mod Pathol; 1996 Apr; 9(4):392-6. PubMed ID: 8729978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the p53 gene and apoptosis in gestational trophoblastic disease.
    Halperin R; Peller S; Sandbank J; Bukovsky I; Schneider D
    Placenta; 2000 Jan; 21(1):58-62. PubMed ID: 10692252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell proliferative activity and mutation of P53 suppressor gene in human gestational trophoblastic disease.
    Persaud V; Ganjei P; Nadji M
    West Indian Med J; 1993 Dec; 42(4):142-3. PubMed ID: 7909185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of maspin in gestational trophoblastic disease.
    Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
    Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
    Hussein MR
    Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression.
    Wong SY; Ngan HY; Chan CC; Cheung AN
    Mod Pathol; 1999 Nov; 12(11):1025-33. PubMed ID: 10574599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mcl-1 expression in gestational trophoblastic disease correlates with clinical outcome: a differential expression study.
    Fong PY; Xue WC; Ngan HY; Chan KY; Khoo US; Tsao SW; Chiu PM; Man LS; Cheung AN
    Cancer; 2005 Jan; 103(2):268-76. PubMed ID: 15578716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of p53 gene mutations in human gestational trophoblastic neoplasia by polymerase chain reaction-single strand conformational polymorphism techniques].
    Wu Y; Zhang Q; Tang H
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(4):338-40. PubMed ID: 9868092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
    Niemann I; Hansen ES; Sunde L
    Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diploid hydatidiform moles with fetal red blood cells in molar villi. 2--Genetics.
    Fisher RA; Paradinas FJ; Soteriou BA; Foskett M; Newlands ES
    J Pathol; 1997 Feb; 181(2):189-95. PubMed ID: 9120724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The villous stromal constituents of complete hydatidiform mole differ histologically in very early pregnancy from the normally developing placenta.
    Kim KR; Park BH; Hong YO; Kwon HC; Robboy SJ
    Am J Surg Pathol; 2009 Feb; 33(2):176-85. PubMed ID: 18936691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in gene expression profiles of hydatidiform mole and choriocarcinoma as compared with trophoblast hyperplasia].
    Cui JQ; Shi YF; Zhou HJ; Li JQ
    Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):727-31. PubMed ID: 15733390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association of the novel hydatidiform mole-related gene F10 with the invasiveness of trophoblastic tumor].
    Zhou J; Chen SL; Xing FQ; Pang ZJ; Li B; Zhou WQ; Fu X; Ding YQ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):171-3. PubMed ID: 15698997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-myc, c-erbB-2, c-fms and bcl-2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma.
    Fulop V; Mok SC; Genest DR; Szigetvari I; Cseh I; Berkowitz RS
    J Reprod Med; 1998 Feb; 43(2):101-10. PubMed ID: 9513871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The study of DNA fingerprint of hydatidiform moles and the clinical outcome].
    Zhang X; Zhang L; Zhou X
    Zhonghua Fu Chan Ke Za Zhi; 1996 Apr; 31(4):203-5. PubMed ID: 8758772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial recurrent hydatidiform mole: a review.
    Fisher RA; Hodges MD; Newlands ES
    J Reprod Med; 2004 Aug; 49(8):595-601. PubMed ID: 15457849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mismatch repair gene promoter methylation and expression in hydatidiform moles.
    Chen H; Ye D; Xie X; Lu W; Zhu C; Chen X
    Arch Gynecol Obstet; 2005 Jun; 272(1):35-9. PubMed ID: 15338238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation of SOX2 gene in hydatidiform mole and choriocarcinoma.
    Li AS; Siu MK; Zhang H; Wong ES; Chan KY; Ngan HY; Cheung AN
    Reprod Sci; 2008 Sep; 15(7):735-44. PubMed ID: 18836133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric analysis of DNA content in partial hydatidiform moles with persistent gestational trophoblastic tumor.
    Lage JM; Berkowitz RS; Rice LW; Goldstein DP; Bernstein MR; Weinberg DS
    Obstet Gynecol; 1991 Jan; 77(1):111-5. PubMed ID: 1845777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.